Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Mar-24 8:51 PM View:  | Cobb Stuart Chief Scientific Officer | Neurogene Inc. (NGNE) | 13-Mar-24 | Grant | 20,391 | -- | -- | 100% 0 to 20.39K | |
| 14-Mar-24 8:53 PM View: | Cvijic Christine Mikail President and CFO | Neurogene Inc. (NGNE) | 13-Mar-24 | Grant | 31,903 | -- | -- | 152% 20.94K to 52.84K | |
| 10-Oct-23 4:22 PM View: | Baker Bros Advisors LLC Director 10% Owner | Neurogene Inc. (NGNE) | 05-Oct-23 | Exercise (in-the money or at-the-money) | 592,650 | -- | -- | 48% 1.22M to 1.81M | |
| 17-Aug-23 5:08 PM View: | Baker Bros Advisors LLC Director 10% Owner | Neurogene Inc. (NGNE) | 17-Aug-23 | Purchase | 166,942 | $0.69 | $115,617.00 | 3% 5.94M to 6.11M | |
| 17-Aug-23 5:08 PM View: | Baker Bros Advisors LLC Director 10% Owner | Neurogene Inc. (NGNE) | 16-Aug-23 | Purchase | 229,600 | $0.68 | $156,254.00 | 4% 5.72M to 5.94M | |
| 17-Aug-23 5:08 PM View: | Baker Bros Advisors LLC Director 10% Owner | Neurogene Inc. (NGNE) | 15-Aug-23 | Private Purchase | 1,888,800 | $0.63 | $1,191,620.00 | 49% 3.83M to 5.72M | |
| 14-Aug-23 4:06 PM View: | Smith Sean Michael Interim CFO, Prin Acct Off | Neurogene Inc. (NGNE) | 11-Aug-23 | Option Sale | 1,323 | $0.62 | $818.14 | (6%) 22.96K to 21.64K | |
| 14-Aug-23 4:06 PM View: | Smith Sean Michael Interim CFO, Prin Acct Off | Neurogene Inc. (NGNE) | 10-Aug-23 | Option Exercise | 5,000 | -- | -- | 28% 17.96K to 22.96K | |
| 04-Apr-23 8:51 PM View: | Patel Priti | Neurogene Inc. (NGNE) | 03-Apr-23 | Option Sale | 3,769 | $0.69 | $2,607.77 | (9%) 41.08K to 37.31K | |
| 04-Apr-23 8:51 PM View: | Patel Priti | Neurogene Inc. (NGNE) | 31-Mar-23 | Option Exercise | 10,000 | -- | -- | 32% 31.08K to 41.08K | |
| 03-Feb-23 4:33 PM View: | Smith Sean Michael Principal Accounting Officer | Neurogene Inc. (NGNE) | 02-Feb-23 | Option Sale | 3,316 | $0.60 | $1,980.32 | (17%) 19.28K to 15.96K | |
| 03-Feb-23 4:32 PM View: | Patel Priti Chief Medical Officer | Neurogene Inc. (NGNE) | 02-Feb-23 | Option Sale | 14,380 | $0.60 | $8,587.74 | (32%) 45.46K to 31.08K | |
| 03-Feb-23 4:33 PM View: | Smith Sean Michael Principal Accounting Officer | Neurogene Inc. (NGNE) | 01-Feb-23 | Option Exercise | 12,500 | -- | -- | 184% 6.78K to 19.28K | |
| 03-Feb-23 4:32 PM View: | Patel Priti Chief Medical Officer | Neurogene Inc. (NGNE) | 01-Feb-23 | Option Exercise | 35,000 | -- | -- | 335% 10.46K to 45.46K | |
| 12-Aug-22 5:24 PM View: | Smith Sean Michael Principal Accounting Officer | Neurogene Inc. (NGNE) | 10-Aug-22 | Option Exercise | 5,000 | -- | -- | 146% 3.43K to 8.43K | |
| 12-Aug-22 5:24 PM View: | Smith Sean Michael Principal Accounting Officer | Neurogene Inc. (NGNE) | 10-Aug-22 | Option Sale | 1,655 | $0.99 | $1,640.77 | (20%) 8.43K to 6.78K | |
| 03-May-22 7:16 PM View: | Patel Priti Chief Medical Officer | Neurogene Inc. (NGNE) | 02-May-22 | Option Sale | 5,538 | $1.22 | $6,748.61 | (46%) 12.0K to 6.46K | |
| 03-May-22 7:16 PM View: | Patel Priti Chief Medical Officer | Neurogene Inc. (NGNE) | 30-Apr-22 | Option Exercise | 10,000 | -- | -- | 500% 2.0K to 12.0K | |
| 14-Feb-22 10:00 PM View: | Drachman Jonathan G President and CEO Director | Neurogene Inc. (NGNE) | 26-Oct-21 | Gift | 150,000 | -- | -- | 6% 2.4M to 2.55M | |
| 14-Feb-22 10:00 PM View: | Drachman Jonathan G President and CEO Director | Neurogene Inc. (NGNE) | 26-Oct-21 | Gift | 150,000 | -- | -- | (6%) 2.55M to 2.4M | |
| 26-Aug-21 7:08 PM View: | Drachman Jonathan G President and CEO Director | Neurogene Inc. (NGNE) | 25-Aug-21 | Market Purchase | 50,000 | $6.45 | $322,450.00 | 2% 2.35M to 2.4M | |
| 26-Aug-21 7:08 PM View: | Drachman Jonathan G President and CEO Director | Neurogene Inc. (NGNE) | 24-Aug-21 | Market Purchase | 100,000 | $6.11 | $611,100.00 | 4% 2.25M to 2.35M | |
| 17-Jun-21 9:46 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 16-Jun-21 | Market Sale (Planned) | 600 | $10.19 | $6,114.00 | (< 1%) 1.35M to 1.35M | 1% |
| 11-Jun-21 4:13 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 09-Jun-21 | Market Sale (Planned) | 650 | $10.82 | $7,035.99 | (< 1%) 1.35M to 1.35M | 2% |
| 09-Jun-21 5:22 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 08-Jun-21 | Market Sale (Planned) | 600 | $11.00 | $6,600.00 | (< 1%) 1.35M to 1.35M | |
| 07-Jun-21 5:07 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 04-Jun-21 | Market Sale (Planned) | 600 | $10.00 | $6,000.00 | (< 1%) 1.35M to 1.35M | 3% |
| 07-Jun-21 5:06 PM View: | Drachman Jonathan G President and CEO Director | Neurogene Inc. (NGNE) | 04-Jun-21 | Market Purchase | 10,000 | $9.61 | $96,082.00 | < 1% 2.24M to 2.25M | < 1% |
| 07-Jun-21 5:06 PM View: | Drachman Jonathan G President and CEO Director | Neurogene Inc. (NGNE) | 03-Jun-21 | Market Purchase | 40,000 | $9.48 | $379,272.00 | 2% 2.2M to 2.24M | 2% |
| 26-May-21 7:37 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 26-May-21 | Market Sale (Planned) | 600 | $10.00 | $6,000.00 | (< 1%) 1.36M to 1.35M | 1% |
| 21-May-21 5:24 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 19-May-21 | Market Sale (Planned) | 600 | $10.63 | $6,378.00 | (< 1%) 1.36M to 1.36M | 2% |
| 12-May-21 8:53 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 12-May-21 | Market Sale (Planned) | 1,200 | $11.09 | $13,308.00 | (< 1%) 1.36M to 1.35M | (3%) |
| 06-May-21 5:28 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 05-May-21 | Market Sale (Planned) | 1,200 | $11.30 | $13,560.00 | (< 1%) 1.36M to 1.36M | (11%) |
| 30-Apr-21 5:52 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 28-Apr-21 | Market Sale (Planned) | 2,400 | $12.58 | $30,192.00 | (< 1%) 1.36M to 1.36M | (3%) |
| 27-Apr-21 7:59 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 26-Apr-21 | Market Sale (Planned) | 600 | $13.00 | $7,800.00 | (< 1%) 1.36M to 1.36M | (< 1%) |
| 22-Apr-21 5:11 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 21-Apr-21 | Market Sale (Planned) | 1,800 | $11.98 | $21,564.00 | (< 1%) 1.36M to 1.36M | (3%) |
| 16-Apr-21 10:00 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 14-Apr-21 | Market Sale (Planned) | 1,800 | $12.22 | $21,996.00 | (< 1%) 1.36M to 1.36M | < 1% |
| 08-Apr-21 7:06 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 07-Apr-21 | Market Sale (Planned) | 1,800 | $12.02 | $21,636.00 | (< 1%) 1.37M to 1.36M | (1%) |
| 06-Apr-21 8:37 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 05-Apr-21 | Market Sale (Planned) | 600 | $13.00 | $7,800.00 | (< 1%) 1.37M to 1.37M | (< 1%) |
| 02-Apr-21 5:21 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 31-Mar-21 | Market Sale (Planned) | 1,800 | $11.96 | $21,528.00 | (< 1%) 1.37M to 1.37M | 2% |
| 24-Mar-21 6:48 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 24-Mar-21 | Market Sale (Planned) | 1,800 | $11.95 | $21,515.90 | (< 1%) 1.37M to 1.37M | < 1% |
| 24-Mar-21 6:48 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 22-Mar-21 | Market Sale (Planned) | 600 | $12.00 | $7,200.00 | (< 1%) 1.37M to 1.37M | < 1% |
| 18-Mar-21 8:45 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 17-Mar-21 | Market Sale (Planned) | 1,200 | $11.36 | $13,632.00 | (< 1%) 1.37M to 1.37M | < 1% |
| 18-Mar-21 8:44 PM View: | Ho Robert Chief Financial Officer | Neurogene Inc. (NGNE) | 17-Mar-21 | Market Option Sale | 6,497 | $11.01 | $71,556.00 | (23%) 28.0K to 21.5K | |
| 18-Mar-21 8:44 PM View: | Ho Robert Chief Financial Officer | Neurogene Inc. (NGNE) | 16-Mar-21 | Option Exercise | 25,000 | -- | -- | 833% 3.0K to 28.0K | |
| 11-Mar-21 4:14 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 10-Mar-21 | Market Sale (Planned) | 1,800 | $11.97 | $21,540.10 | (< 1%) 1.37M to 1.37M | 2% |
| 04-Mar-21 6:52 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 03-Mar-21 | Market Sale (Planned) | 1,800 | $11.87 | $21,360.10 | (< 1%) 1.38M to 1.37M | (1%) |
| 25-Feb-21 8:17 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 25-Feb-21 | Market Sale (Planned) | 600 | $13.00 | $7,800.00 | (< 1%) 1.38M to 1.38M | 4% |
| 25-Feb-21 8:17 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 24-Feb-21 | Market Sale (Planned) | 1,800 | $12.14 | $21,852.00 | (< 1%) 1.38M to 1.38M | (2%) |
| 18-Feb-21 4:20 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 17-Feb-21 | Market Sale (Planned) | 2,400 | $12.70 | $30,480.00 | (< 1%) 1.38M to 1.38M | 2% |
| 12-Feb-21 4:23 PM View: | Walkey Carl Senior Vice President | Neurogene Inc. (NGNE) | 10-Feb-21 | Market Sale (Planned) | 3,000 | $14.20 | $42,600.00 | (< 1%) 1.38M to 1.38M | 12% |
